Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension

NCT07641296 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: BIM-DRS Low Dose
DRUG: BIM-DRS High Dose
DEVICE: SpyGlass IOL with silicone pads (no drug)

Sponsor

SpyGlass Pharma, Inc.